Covid-19: Oxford halts AstraZeneca vaccine study in kids over possible blood clots

0:00
play article
Subscribers can listen to this article
Vials and syringe in front of an AstraZeneca logo.
Vials and syringe in front of an AstraZeneca logo.
John Beckmann/BSR Agency/Getty Images

The University of Oxford said on Tuesday it had paused a small UK trial testing the Covid-19 vaccine it developed with AstraZeneca Plc in children and teenagers, as it waits for more data on rare blood clotting issues in adults who received the shot.

The trial disruption is the latest blow to the vaccine, once hailed as a milestone in the fight against the pandemic, after several countries restricted its use in light of reports of medical issues after inoculations.

There were no safety concerns in the pediatric trial, Oxford University said, adding that it would await guidance from the UK drugs watchdog before giving any further vaccinations.

The university said in February it planned to enroll 300 volunteers aged 6-17 years, based in the United Kingdom, as part of this study.

The European Medicines Agency (EMA) is currently reviewing reports of an extremely rare brain blood clot known as cerebral venous sinus thrombosis (CVST) after the AstraZeneca shots, and is expected to announce its findings on Wednesday or Thursday.

A senior EMA official has said there is a clear association between the vaccine and CVST, though the direct cause of the clots is still unknown.

Spats with governments across Europe about production, supplies, possible side effects and the vaccine's merits have dogged the Anglo-Swedish drugmaker for months.


We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
Lockdown For
DAYS
HRS
MINS
Voting Booth
Would you choose to continue working from home after the coronavirus lockdown if given the option?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes, it's much better for me
40% - 6987 votes
No ways! I can't wait to get back to the office
12% - 2039 votes
A mixture of both would suit me best
48% - 8398 votes
Vote
USD/ZAR
14.57
(-0.2)
GBP/ZAR
20.02
(-0.0)
EUR/ZAR
17.36
(-0.0)
AUD/ZAR
11.11
(-0.2)
JPY/ZAR
0.13
(+0.0)
Gold
1,732.78
(-0.6)
Silver
24.81
(-1.8)
Platinum
1,175.50
(-2.4)
Brent Crude
62.95
(-0.4)
Palladium
2,672.00
(+1.1)
All Share
66,390
(-1.2)
Top 40
60,673
(-1.3)
Financial 15
12,144
(+0.2)
Industrial 25
86,617
(-1.1)
Resource 10
67,175
(-2.1)
All JSE data delayed by at least 15 minutes Iress logo